Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
66.05 EUR | -5.37% |
|
-4.54% | -5.34% |
Jul. 09 | Wacker Chemie expands bio research in Munich | DP |
Jul. 07 | DZ Bank downgrades Wacker Chemie to 'Hold' – fair value €70 | DP |
Company Valuation: Wacker Chemie AG
Data adjusted to current consolidation scope
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 5,800 | 6,538 | 5,932 | 5,678 | 3,479 | 3,468 | - | - |
Change | - | 12.72% | -9.27% | -4.27% | -38.72% | -0.34% | - | - |
Enterprise Value (EV) 1 | 5,867 | 5,991 | 5,522 | 5,762 | 4,170 | 4,199 | 4,008 | 3,827 |
Change | - | 2.11% | -7.82% | 4.34% | -27.63% | 0.69% | -4.55% | -4.52% |
P/E ratio | 30.6x | 8.1x | 4.74x | 18.1x | 14.4x | 40.9x | 16.7x | 12.4x |
PBR | 3.57x | 2.17x | 1.22x | 1.29x | 0.75x | 0.76x | 0.72x | 0.69x |
PEG | - | 0x | 0.1x | -0.2x | -0.6x | -0.6x | 0x | 0.4x |
Capitalization / Revenue | 1.24x | 1.05x | 0.72x | 0.89x | 0.61x | 0.6x | 0.56x | 0.54x |
EV / Revenue | 1.25x | 0.97x | 0.67x | 0.9x | 0.73x | 0.72x | 0.65x | 0.59x |
EV / EBITDA | 8.81x | 3.89x | 2.65x | 7x | 5.47x | 6.26x | 4.81x | 4.11x |
EV / EBIT | 22.3x | 5.28x | 3.29x | 14.2x | 14.4x | 23.6x | 12.6x | 9.11x |
EV / FCF | 9.07x | 8.31x | 9.54x | 25.4x | -11.7x | 23.5x | 13.4x | 13.3x |
FCF Yield | 11% | 12% | 10.5% | 3.93% | -8.53% | 4.25% | 7.45% | 7.53% |
Dividend per Share 2 | 2 | 8 | 12 | 3 | 2.5 | 1.168 | 2.238 | 2.922 |
Rate of return | 1.71% | 6.08% | 10.1% | 2.62% | 3.57% | 1.67% | 3.21% | 4.19% |
EPS 2 | 3.81 | 16.24 | 25.18 | 6.31 | 4.85 | 1.705 | 4.187 | 5.62 |
Distribution rate | 52.5% | 49.3% | 47.7% | 47.5% | 51.5% | 68.5% | 53.4% | 52% |
Net sales 1 | 4,692 | 6,208 | 8,209 | 6,402 | 5,722 | 5,801 | 6,145 | 6,476 |
EBITDA 1 | 666.3 | 1,538 | 2,081 | 823.6 | 762.8 | 670.3 | 832.5 | 930.7 |
EBIT 1 | 262.8 | 1,134 | 1,679 | 404.9 | 290.1 | 178.3 | 318.1 | 419.9 |
Net income 1 | 189.2 | 806.9 | 1,251 | 313.6 | 241 | 92.04 | 214.7 | 285.7 |
Net Debt 1 | 67.5 | -546.5 | -409.2 | 83.7 | 690.6 | 731.3 | 540.3 | 359.3 |
Reference price 2 | 116.75 | 131.60 | 119.40 | 114.30 | 70.04 | 69.80 | 69.80 | 69.80 |
Nbr of stocks (in thousands) | 49,678 | 49,678 | 49,678 | 49,678 | 49,678 | 49,678 | - | - |
Announcement Date | 3/16/21 | 3/15/22 | 3/14/23 | 3/15/24 | 3/11/25 | - | - | - |
1EUR in Million2EUR
Estimates
P/E ratio, Detailed evolution
P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
---|---|---|---|---|---|---|
40.93x | 0.72x | 6.26x | 1.67% | 4.03B | ||
14.92x | 1.75x | 9.55x | 4.11% | 3.27B | ||
21.11x | 1.77x | 10.58x | 2.88% | 1.62B | ||
-35.54x | 0.79x | 7.01x | 2.06% | 1.45B | ||
12.89x | - | - | - | 674M | ||
94.1x | - | - | 0.34% | 643M | ||
15.89x | - | - | 4.21% | 320M | ||
Average | 23.47x | 1.26x | 8.35x | 2.54% | 1.71B | |
Weighted average by Cap. | 22.55x | 1.22x | 8.08x | 2.6% |
Year-on-year evolution of the PER
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- WCH Stock
- Valuation Wacker Chemie AG
Select your edition
All financial news and data tailored to specific country editions